Although preclinical studies link GLP-1 signaling to brown adipose tissue (BAT) activation and adipose tissue browning, human data indicate that BAT mass and thermogenic capacity in adulthoodparticularly in obesityare limited, constraining the contribution of energy expenditure to sustained weight loss
Subcutaneous injections hurt less than intramuscular
Due to its unique triple-action on GLP-1, GIP and glucagon receptors , Retatrutide is considered one of the most advanced peptides in this research field
Youve likely heard about the incredible results of GLP-1 (glucagon-like peptide-1) medications, such as semaglutide, liraglutide, and tirzepatide, for weight loss in obese and overweight patients and type 2 diabetes mellitus
Patients enrolled in the Transition Anywhere virtual program have access to prescription weight loss medications, including GLP-1 injections, as part of their medically supervised plan